GoldenGolden
Advanced Search
Sanofi Ventures

Sanofi Ventures

Sanofi Ventures is the corporate venture capital arm of Sanofi.

Sanofi Ventures is a venture capital that invests in early-stage biotech as well as digital health companies that have innovative ideas and transformative projects.

Leading companies that are finding solutions for rare diseases, oncology, immunology, inflammation, vaccines, as well as digital health solutions are the primary target for Sanofi Ventures. Sanofi Ventures is interested in companies such as Aetion, Click Therapeutics, Common Sensing, Curisium, evidation, Expansion Therapeutics, Fulcrum Therapeutics, and icosavax.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
FinSMEs
May 10, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
May 10, 2021
BioSpace
Therini Bio Secures $17 Million Investment to Advance Fibrin Therapeutic Candidates Towards the Clinic - read this article along with other careers information, tips and advice on BioSpace
Therini Bio, Inc.
May 10, 2021
www.prnewswire.com:443
/PRNewswire/ -- Therini Bio, Inc. announced it has completed an oversubscribed Seed Extension round of financing. The capital will accelerate the development...
MinervaX
December 15, 2020
www.prnewswire.com:443
/PRNewswire/ -- MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), announced today that it...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.